| Gina Waymire, MD | |
|
1100 Central Ave Se, Albuquerque, NM 87106-4930 | |
| (505) 841-1063 | |
| (505) 724-7042 |
| Full Name | Gina Waymire |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 1100 Central Ave Se, Albuquerque, New Mexico |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275556375 | NPI | - | NPPES |
| 72486 | Medicaid | NM |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 99324 (New Mexico) | Primary |
| Entity Name | Presbyterian Healthcare Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104802354 PECOS PAC ID: 9234041708 Enrollment ID: O20031103000603 |
News Archive
The discovery of new genetic mutations involved in inflammatory intestinal disorders could lead to a better understanding of these common conditions, two scientists told the annual conference of the European Society of Human Genetics today (Monday 2 June).
Cambrex Corporation (the "Company") announced that it has received a warning letter from the U.S. Food and Drug Administration ("FDA") relating to an inspection of the Company's generic active pharmaceutical ingredient ("API") manufacturing facility located in Milan, Italy in March 2009. The observations noted in the warning letter are primarily related to the collection and maintenance of certain laboratory data.
While transgender and gender-diverse individuals have historically been disproportionately susceptible to violence and homicides, the recent rise in visibility of ongoing trans-focused violence has highlighted how the medical-legal community, in general and forensic anthropology, in particular, have largely neglected trans and gender-diverse people.
Corindus Vascular Robotics announced the results of the first clinical study of the CorPath 200 System and invites attendees of the Transcatheter Cardiovascular Therapeutics (TCT) 2010 conference (September 21-25 in Washington, DC) to experience firsthand the CorPath 200 System.
Patients with lupus who take their medications as prescribed have much lower odds of developing type 2 diabetes, a common complication of the disease, finds a new study from the University of British Columbia.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gina Waymire, MD Po Box 26666, Phs Provider Enrollment, Albuquerque, NM 87125-6666 Ph: (505) 923-6770 | Gina Waymire, MD 1100 Central Ave Se, Albuquerque, NM 87106-4930 Ph: (505) 841-1063 |
News Archive
The discovery of new genetic mutations involved in inflammatory intestinal disorders could lead to a better understanding of these common conditions, two scientists told the annual conference of the European Society of Human Genetics today (Monday 2 June).
Cambrex Corporation (the "Company") announced that it has received a warning letter from the U.S. Food and Drug Administration ("FDA") relating to an inspection of the Company's generic active pharmaceutical ingredient ("API") manufacturing facility located in Milan, Italy in March 2009. The observations noted in the warning letter are primarily related to the collection and maintenance of certain laboratory data.
While transgender and gender-diverse individuals have historically been disproportionately susceptible to violence and homicides, the recent rise in visibility of ongoing trans-focused violence has highlighted how the medical-legal community, in general and forensic anthropology, in particular, have largely neglected trans and gender-diverse people.
Corindus Vascular Robotics announced the results of the first clinical study of the CorPath 200 System and invites attendees of the Transcatheter Cardiovascular Therapeutics (TCT) 2010 conference (September 21-25 in Washington, DC) to experience firsthand the CorPath 200 System.
Patients with lupus who take their medications as prescribed have much lower odds of developing type 2 diabetes, a common complication of the disease, finds a new study from the University of British Columbia.
› Verified 7 days ago
Janell Fuller, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 3rd Ambulatory Care Ctr, 2211 Lomas Blvd. Ne, Albuquerque, NM 87131 Phone: 505-272-2345 | |
Ivana Radovanovic, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 2211 Lomas Ne Acc 3w, Albuquerque, NM 87131 Phone: 505-272-6632 Fax: 505-272-6620 | |
Lynn Longfield, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 4420 Irving Blvd Nw, Albuquerque, NM 87114 Phone: 505-823-1010 Fax: 505-797-4503 | |
Thomas Rothfeld, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 401 San Mateo Blvd Se, Pmg San Mateo, Albuquerque, NM 87108 Phone: 505-462-7306 Fax: 505-462-7495 | |
Dr. Leslie Erin Strickler, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 2211 Lomas Blvd Ne, Albuquerque, NM 87106 Phone: 505-272-5551 Fax: 505-272-6845 | |
Jennifer M Garcia, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 2001 El Centro Familiar Blvd Sw, Albuquerque, NM 87105 Phone: 505-873-7400 Fax: 505-224-8797 | |
Dr. William B Hawk, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 5904 Holly Ave Ne, Albuquerque, NM 87113 Phone: 505-298-2505 Fax: 505-298-2985 |